Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Transdermal Skin Patch Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Transdermal Skin Patch Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Fentanyl Transdermal Skin Patch
      • 1.3.3 Nicotine Transdermal Skin Patch
      • 1.3.4 Clonidine Transdermal Skin Patch
      • 1.3.5 Buprenorphine Transdermal Skin Patch
    • 1.4 Market Segment by Application
      • 1.4.1 Global Transdermal Skin Patch Market Share by Application (2019-2025)
      • 1.4.2 Relieve Severe Pain
      • 1.4.3 Stop Smoking Cigarettes
      • 1.4.4 Treat An Overactive Bladder
      • 1.4.5 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Transdermal Skin Patch Market Size
      • 2.1.1 Global Transdermal Skin Patch Revenue 2014-2025
      • 2.1.2 Global Transdermal Skin Patch Sales 2014-2025
    • 2.2 Transdermal Skin Patch Growth Rate by Regions
      • 2.2.1 Global Transdermal Skin Patch Sales by Regions 2014-2019
      • 2.2.2 Global Transdermal Skin Patch Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Transdermal Skin Patch Sales by Manufacturers
      • 3.1.1 Transdermal Skin Patch Sales by Manufacturers 2014-2019
      • 3.1.2 Transdermal Skin Patch Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Transdermal Skin Patch Revenue by Manufacturers (2014-2019)
      • 3.2.2 Transdermal Skin Patch Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Transdermal Skin Patch Market Concentration Ratio (CR5 and HHI)
    • 3.3 Transdermal Skin Patch Price by Manufacturers
    • 3.4 Key Manufacturers Transdermal Skin Patch Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Transdermal Skin Patch Market
    • 3.6 Key Manufacturers Transdermal Skin Patch Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Fentanyl Transdermal Skin Patch Sales and Revenue (2014-2019)
      • 4.1.2 Nicotine Transdermal Skin Patch Sales and Revenue (2014-2019)
      • 4.1.3 Clonidine Transdermal Skin Patch Sales and Revenue (2014-2019)
      • 4.1.4 Buprenorphine Transdermal Skin Patch Sales and Revenue (2014-2019)
    • 4.2 Global Transdermal Skin Patch Sales Market Share by Type
    • 4.3 Global Transdermal Skin Patch Revenue Market Share by Type
    • 4.4 Transdermal Skin Patch Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Transdermal Skin Patch Sales by Application

    6 United States

    • 6.1 United States Transdermal Skin Patch Breakdown Data by Company
    • 6.2 United States Transdermal Skin Patch Breakdown Data by Type
    • 6.3 United States Transdermal Skin Patch Breakdown Data by Application

    7 European Union

    • 7.1 European Union Transdermal Skin Patch Breakdown Data by Company
    • 7.2 European Union Transdermal Skin Patch Breakdown Data by Type
    • 7.3 European Union Transdermal Skin Patch Breakdown Data by Application

    8 China

    • 8.1 China Transdermal Skin Patch Breakdown Data by Company
    • 8.2 China Transdermal Skin Patch Breakdown Data by Type
    • 8.3 China Transdermal Skin Patch Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Transdermal Skin Patch Breakdown Data by Company
    • 9.2 Rest of World Transdermal Skin Patch Breakdown Data by Type
    • 9.3 Rest of World Transdermal Skin Patch Breakdown Data by Application
    • 9.4 Rest of World Transdermal Skin Patch Breakdown Data by Countries
      • 9.4.1 Rest of World Transdermal Skin Patch Sales by Countries
      • 9.4.2 Rest of World Transdermal Skin Patch Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Hisamitsu Pharmaceutical
      • 10.1.1 Hisamitsu Pharmaceutical Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Transdermal Skin Patch
      • 10.1.4 Transdermal Skin Patch Product Introduction
      • 10.1.5 Hisamitsu Pharmaceutical Recent Development
    • 10.2 Novartis
      • 10.2.1 Novartis Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Transdermal Skin Patch
      • 10.2.4 Transdermal Skin Patch Product Introduction
      • 10.2.5 Novartis Recent Development
    • 10.3 Johnson & Johnson
      • 10.3.1 Johnson & Johnson Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Transdermal Skin Patch
      • 10.3.4 Transdermal Skin Patch Product Introduction
      • 10.3.5 Johnson & Johnson Recent Development
    • 10.4 Teikoku Pharma
      • 10.4.1 Teikoku Pharma Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Transdermal Skin Patch
      • 10.4.4 Transdermal Skin Patch Product Introduction
      • 10.4.5 Teikoku Pharma Recent Development
    • 10.5 Mylan
      • 10.5.1 Mylan Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Transdermal Skin Patch
      • 10.5.4 Transdermal Skin Patch Product Introduction
      • 10.5.5 Mylan Recent Development
    • 10.6 Actavis
      • 10.6.1 Actavis Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Transdermal Skin Patch
      • 10.6.4 Transdermal Skin Patch Product Introduction
      • 10.6.5 Actavis Recent Development
    • 10.7 Mundipharma
      • 10.7.1 Mundipharma Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Transdermal Skin Patch
      • 10.7.4 Transdermal Skin Patch Product Introduction
      • 10.7.5 Mundipharma Recent Development
    • 10.8 Henan Lingrui Pharmaceutical
      • 10.8.1 Henan Lingrui Pharmaceutical Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Transdermal Skin Patch
      • 10.8.4 Transdermal Skin Patch Product Introduction
      • 10.8.5 Henan Lingrui Pharmaceutical Recent Development
    • 10.9 Changzhou Siyao
      • 10.9.1 Changzhou Siyao Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Transdermal Skin Patch
      • 10.9.4 Transdermal Skin Patch Product Introduction
      • 10.9.5 Changzhou Siyao Recent Development
    • 10.10 Rfl Pharmaceutical
      • 10.10.1 Rfl Pharmaceutical Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Transdermal Skin Patch
      • 10.10.4 Transdermal Skin Patch Product Introduction
      • 10.10.5 Rfl Pharmaceutical Recent Development
    • 10.11 Luye Pharma Group Ltd.
    • 10.12 Purdue Pharma L.P.
    • 10.13 Teva Pharmaceutical Industries Ltd.

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Transdermal Skin Patch Sales Channels
      • 11.2.2 Transdermal Skin Patch Distributors
    • 11.3 Transdermal Skin Patch Customers

    12 Market Forecast

    • 12.1 Global Transdermal Skin Patch Sales and Revenue Forecast 2019-2025
    • 12.2 Global Transdermal Skin Patch Sales Forecast by Type
    • 12.3 Global Transdermal Skin Patch Sales Forecast by Application
    • 12.4 Transdermal Skin Patch Forecast by Regions
      • 12.4.1 Global Transdermal Skin Patch Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Transdermal Skin Patch Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Transdermal Skin Patch is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Transdermal Skin Patch.

      This report studies the global market size of Transdermal Skin Patch, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Transdermal Skin Patch sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Hisamitsu Pharmaceutical
      Novartis
      Johnson & Johnson
      Teikoku Pharma
      Mylan
      Actavis
      Mundipharma
      Henan Lingrui Pharmaceutical
      Changzhou Siyao
      Rfl Pharmaceutical
      Luye Pharma Group Ltd.
      Purdue Pharma L.P.
      Teva Pharmaceutical Industries Ltd.

      Market Segment by Product Type
      Fentanyl Transdermal Skin Patch
      Nicotine Transdermal Skin Patch
      Clonidine Transdermal Skin Patch
      Buprenorphine Transdermal Skin Patch

      Market Segment by Application
      Relieve Severe Pain
      Stop Smoking Cigarettes
      Treat An Overactive Bladder
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Transdermal Skin Patch status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Transdermal Skin Patch manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Transdermal Skin Patch are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now